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For fair Caucasian skin, the minimal delayed erythema 
dose (MED) 24 hr after exposure to broadband UV A is 
about 1200 times greater than the MED of broadband 
UVB, for both single and multiple daily exposures. Re-
peated daily exposure to doses less than MED results in 
cumulative effects manifest by gradual lowering of the 
daily dose threshold for delayed erythema and pigmen-
tation induced by UV A or UVB. At threshold doses, UVB 
is more erythemogenic than melanogenic; the opposite 
is true for UV A. Repeated daily UV A exposure greatly 
enhances melanogenesis such that markedly subery-
themogenic exposure doses ofUV A result in true melan-
ogenesis. 
The minimal delayed erythema dose (MED) is a much-used 
endpoint in cutaneous photobiology. It is often assumed that 
ultraviolet exposure doses less than the MED have little effect 
on skin and certainly cause no lasting changes. However, it has 
r ecently been shown that single exposure doses less than MED 
damage DNA in viable keratinocytes [1], produce epidermal 
cell death [2], and induce melanin pigmentation [3-5]. We show 
h ere for t h e first time that multiple daily exposures of normal 
human skin to broadband UV A or UVB at doses below MED 
lead to cumulative alterations of normal human skin, manifest 
by a lowering of the threshold, in terms of the daily exposure 
dose, for delayed erythema and for true melanogenesis. 
MATERIALS AND METHODS 
The 2 sides of previously unexposed buttocks of 6 normal Caucasian 
(skin types II and III) [6] adult volunteers were exposed to UV A and 
UVB respectively. The UVA source was a 2500 W xenon arc source 
(Schoeffel Instruments) with an f/1.5 quartz condensing lens system. 
Radiation was filtered through 6 em of a 7% CuSO, and 7% CoSO, 
.aqueous solution, and Schott WG 335 (1 mm) filter, then projected in 
a uniform (±7%) rectangular field onto the skin using a f/4.0 quartz 
lens. lrradiance was 410 W 1m2 • Spectral irradiance of this source is 
shown in Fig I, as measu.red with an IL783 spectroradiometer. The 
UVB source was a 1.2 x 1.2 m. planar bank of closely-spaced fluorescent 
sunlamp bulbs (FS40 Westinghouse). Uniformity of UVB irradiance 
was ±5%, and the UVB irradiance was 5.5 W 1m" as determined by a 
cosine-corrected International Light model 52 UVB detector, with 
spectral responsivity weighted similarly to the action spectrum for 
delayed erythema. Full spectral irradiance of this source is given in Fig 
2, as measured with an IL783 spectroradiometer. UVB exposure doses 
were calculated using the weighted irradiances as measured by the 
model 52 UVB detector. 
MED to both sources was determined using 1 x 1 cm sites and 25% 
geometric increments of exposure dose. A set of 3 rows of 1 x 1 em 
open squares separated by 0.5 em of cov·ered skin were delineated on 
each buttock. One buttock was irradiated with UV A and the other with 
UVB. Based on each subject's MED the following exposure doses were 
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Abbreviations: 
MED: minimal delayed erythema dose 
MMD: minimal melanogenesis dose 
given to inctividual sites on each row: 
MED MED (for UV A onl ) MED MED MED MED 
80 ' 40 . y , 20 ' 10' 5 ' 4 ' 
2/5 MED, 3/5 MED, 4/5 MED, and 5/ 4 MED. Row 1 was irractiated 
with the above doses once daily for 9 consecutive days, row 2 was 
irradiated once daily for 5 days and row 3 was irradiated only once. All 
sites were read immectiately and at 6 hr, 24 hr, 7 days and 14 days after 
exposure. 
Erythema and pigmentation were graded as follows: 
Eryth.ema 
o No response. 
Trace Very faint, minimally perceptible erythema anywhere within 
exposure field. 
± Erythema more than trace filling most but not all of exposw·e 
sites, but with indefinite borders. 
1+ Minimal erythema with 4 defin ite borders. 
2+ More pronounced erythema. 
3+ Erythema with edema. 
4+ Erythema with edema and vesiculation. 
MED was defined as the minimum daily exposure dose which gave 
a 1+ reading at 24 hr post-exposme. 
Pigmentation 
Assessment of pigmentation was visual and according to the following 
grading system: 
o No pigment. 
Trace Very faint, minimally perceptible pigmentation anywhere 
within exposm e field. 
± Pigment more than trace flliing most but not all of expo m e 
sites, but with indefinite borders. 
1 + Minimal pigmentation with four sharp borders. 
2+ Moderate pigmentation. 
3+ Marked pigmentation. 
4+ Severe pigmentation. 
MMD was defined as the minimum daily exposure dose which 
resulted in a 1+ pigmentation reading at 7 days postexposure. Because 
of the design of the experiment, the MED could be assessed 4 t imes (24 
hr after exposures of MED sites and 24 hr after the fu·s t exposm e of 
each row). Delayed erythema 24 hr after 5 daily exposures could be 
assessed twice [24 hr after final expo ure of x5 (row 2) and 24 hr after 
fifth exposure of x9 (row 3)). Delayed erythema 24 h1· after nine 
exposures could be graded only once. Pigmentation 7 to 14 days after 
5 exposures or 9 exposures could also be evaluated only once. In all 
cases where more than one reliable reading was available these numbers 
were averaged. The readings were never more than one exposure 
increment apart. 
ANALYSIS OF DATA 
A 2-tailed t-test for correlated data pairs and small sample 
s ize with unknown population variance was used to test the 
s ignificance of differences between the following parameters: 
UV A MED (Ix vs 5x vs 9x); UVB MED (Ix vs 5x); UVA 
MMD (Ix vs 5x vs 9x); 
UVAMMD 
UVB MMD (Ix vs 5x); UVA MED (Ix vs 5x vs 9x); 
_U_V_B_M_M_D_ UV A MMD, Ix UVB MMD Ix (Ix vs 5x)· vs ' 
UVB MED ' UV A MED, Ix . UVB MED, Ix ' 
UV A MMD (5x) UVB MMD (5x) 
UV A MED (5x) vs. UVB MED (5x) 
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FIG 2, Spectral irradiance of UVB SOUl'ce (FS40), 
RESULTS 
The raw data for daily dose thresholds for delayed erythema 
and pigmentation in each subject are given in Table 1. Table II 
gives results of statistical comparisons based on this data. A 
detlllite decrease in MMD and MED was noted for both the 
UV A and UVB wavebands as the number of exposmes in-
creased. The MMD decreased relatively more than the MED. 
UV A proved to be more melanogenic than erythemogenic, as 
evidenced by MMD/ MED < 1.0, whereas the opposite was true 
for UVB. This was true for both single and multiple exposmes, 
with the discrepancy in this respect between UV A and UVB 
becoming apparently greater as the number of exposw-es in-
creased. The data given are for the MED and MMD as defined , 
and therefore based on readings obtained 24 hI' after exposw-e. 
Identical reduction of threshold was seen for trace and ± 
readings at 24 hr after exposw-e. Whenever erythema was 
present in a site 24 hI' after UVA exposw-e it was also present 
6 hr after exposure, and in some instances 6 hI' erytbema had 
lower thJ'eshold than 24 hJ' erythema. The thJ'eshold for the 6 
hI response also fell with repeated exposw-es. Therefore, using 
any grading endpoint at 6 or 24 hJ' after exposw-e the thresho ld 
for delayed erythema fell with repeated exposures. Sites which 
had no visible reaction after single exposures had clearly visible 
redness after repeated exposures. Because of the design of the 
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study, no single or multiple exposures were adeq uate to cause 
greater than 1 + erythema. 
DISCUSSION 
One important finding of this study is that subthreshold 
exposw-e doses of either UV A or UVB radiation alter the skin 
for periods of days such that the thJ'eshold for subsequent UV-
induced inflammation or pigmentation is decreased. This is of 
practical importance in several respects. Firstly, the use of 
repeated "suberythemogenic" doses based upon a single deter-
mination ofMED dw-ing phototherapy of various skin disorders 
may eventually produce delayed erythema, if a daily "subery-
themogenic" dose of greater than or equal to approximately 
70% of the MED is chosen. Thus, for a fixed daily dose to be 
truly suberythemogenic, it should be somewhat less than 70% 
of the MED as determined from a single exposm e. Secondly, it 
is clearly not the case that subclinical exposures to UV radiation 
have no effect upon the skin; some cell injmy, however subtle, 
must in fact be induced by essentially any exposme dose. Using 
a xenon arc solar simulator, unscheduled repair DNA synthesis 
(induced sparse labeling of viable cells with tritiated thymidine) 
has been found in tanned skin specimens of human volunteers 
irradiated with doses of UV which failed to show any clinical or 
histological evidence of damage [I). Individually "dyskeratotic 
cells" or "sunburn cells" with pyknotic nuclei and eosinophilic 
cytoplasm have been found in normal human skin after as little 
as one-half MED exposme doses using fluorescent UVB bulbs 
[2). 
Mechanistically the fact that prior daily subclinical exposw'es 
affect skin response to UV radiation for a week or more suggests 
either that (1) damage can be accumulated, (2) the release of 
mediators involved in producing delayed erythema or pigmen-
tation aJ'e altered by prior irradiation, (3) "receptors," e.g., 
blood vessels and melanocytes, aJ'e somehow "sensitized" by 
multiple exposw-es, or (4) multiple daily exposmes alter t he 
physical or optical properties of skin such that a greater fTaction 
of the incident dose reaches viable tissues capable of inducing 
delayed erythema or pigmentation. At present, the mecha-
nism(s) for the cumulative effects noted is unknown. 
A second finding of clinical importance is that in fair-skinned 
Caucasians, UV A is more melanogenic than erythemogenic 
(MMD < MED), whereas the opposite is true for UVB. This 
has been previously noted separately for UV A [3-5] and UVB 
[4,7], but direct statistical compaJ'ison of relative tlll'esholds 
were not possible. Perhaps of greater practical importance is 
the fact that multiple daily exposmes result in a greater sepa-
ration of the thJ'eshold for melanogenesis versus erythemoge-
nesis, in favor of inducing melanogenesis. This was true for 
both UV A and UVB wavebands, but was most striking for 
UV A. The reason for this difference is unknown. After 9 daily 
exposures to UV A, the threshold for melanogenesis was reduced 
almost thJ'ee times as much as that for erythemogenesis (Table 
I) . 
In this study multiple exposmes to UVA of approximately 
0.5 x MED as determined in a single exposure induced m arked 
pigmentation with no apparent erythema. The fact that, for 
both wavebands, the MMD decreased relatively more with 
multiple exposures than did the MED may imply that a differ-
ent mechanism is involved in the cumulative effects upon 
melanogenesis as opposed to delayed erythema. However, more 
detailed study of the t ime comse for expression of such cumu-
lative effects for each response is necessary to further address 
this question. 
The mechanisms by which multiple exposures to UV radia-
tion produce cumulative effects upon skin responses remain 
mysterious. Studies of DN A damage and repair, time COurse of 
production of mediators, or physical changes in the skin after 
multiple subclinical exposures may be fruitful in this regard. 
The study reported here shows that such cumulative effects do 
occur to the extent that the clinical expression of both vasodi-
litation and pigmentation is markedly affected . These findings 
aJ'e pertinent to both dermatologic phototherapy and those 
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TABLE I. Daily dose thresholds 
I Exposure 
Subject # 
MED" MMD" MMD/MED 
a. Daily dose thresholds for UV A exposures, x 105 J 1m2 
1 3.70 3.00 0.81 
2 4.60 3.45 0.75 
3 3.50 2.05 0.59 
4 4.60 2.85 0.62 
5 6.50 5.50 0.85 
6 8.00 5.30 0.66 
Mean 5.15 3.70 0.71 
±SD ±1.75 ±1.40 ±O.ll 
Subject # , 
MED" 
1 Exposure 
MMD' MMD/ MED 
b. Daily dose thresholds for UVB exposures, x 102 J/m2 
1 3.17 4.60 1.45 
2 4.75 5.80 1.22 
3 5.47 6.80 1.24 
4 4.30 5.80 1.35 
5 4.60 5.80 1.26 
6 4.13 7.20 1.74 
Mean 4.40 6.00 1.38 
±SD ±0.76 ±0.91 ±0.20 
" MED = Minimal erythema dose. 
b MMD = Minimal melanogenesis dose. 
5 Daily Exposures 
MED MMD MMD/ MED 
2.20 1.50 0.68 
2.80 1.80 0.64 
3.00 1.50 0.50 
2.80 0.90 0.30 
5.20 3.90 0.75 
7.20 0.80 0.11 
3.87 1.73 0.50 
±1.82 ±1.13 ±0.24 
5 Daily Exposures 
MED MMD MMD/ MED 
2.30 2.30 1.00 
4.60 5.30 1.26 
3.30 3,70 1.12 
2.80 3.70 1.32 
3.40 3.40 1.00 
2.60 3.33 1.27 
3.17 3.62 1.16 
±0.82 ±0.97 ±0.14 
MED 
1.50 
2.20 
2.80 
6.40 
3.20 
±2.18 
MED 
3.7 
9 Daily Exposures 
MMD MMD/ MED 
0.70 0.47 
0.70 0.32 
0.50 0.18 
0.80 0.13 
0.67 0.28 
±0.13 ±0.15 
9 Daily Exposures 
MMD 
1.70 
3.7 
2.8 
2.6 
2.70 
± .82 
MMD/ MED 
TABLE n. Statistical comparisons of response thresholds 
UVAMED 
Ix> 5x 
UVAMED 
5x> 9x 
UVA .MMD 
Ix > 5x 
UVAMMD 
5x > 9x 
UVBMED 
Ix > 5x 
UVBMMD 
Ix> 5x 
UVAMMD 
UVAMED 
Ix > 5x 
UVAMMD 
UVAMED 
5x > 9x 
UVBMMD 
UVBMED 
Ix> 5x 
Comparison 
UVB MMD (Ix) UV A MMD (Ix) 
UVB MED (Ix) > UVA MED (Ix) 
UVB MMD (5x) UVA MMD (5x) 
UVB MED (5x) > UV A MED (5x) 
p value 
p ~ .01 
p:5 .05 
p ~ .01 
p ~ .06 
p ~ .01 
p < .01 
p ~ .01 
p ~ .08 
p:5 .05 
p < .01 
p < .01 
receiving daily sun or artificial UV exposures. The effects of 
repeated subclinical, but injurious exposw'es may also consti-
' tute a significant fraction of cumulative or long-term actinic 
changes such as wrinkling or carcinogenesis. 
We wish to thank Kurt Jaenicke for his technical assistance and Dr. 
Kays Kaidbey for advice with this project. 
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